-
1
-
-
0028896881
-
Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast
-
Gutman H, Pollock RE, Janjan NA, Johnson DA: Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg 1995, 180(2):193-199.
-
(1995)
J Am Coll Surg
, vol.180
, Issue.2
, pp. 193-199
-
-
Gutman, H.1
Pollock, R.E.2
Janjan, N.A.3
Johnson, D.A.4
-
2
-
-
0027177649
-
Sarcomatoid neoplasms of the breast: Proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas
-
Foschini MP, Dina RE, Eusebi V: Sarcomatoid neoplasms of the breast: Proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin Diagn Pathol 1993, 10(2):128-136.
-
(1993)
Semin Diagn Pathol
, vol.10
, Issue.2
, pp. 128-136
-
-
Foschini, M.P.1
Dina, R.E.2
Eusebi, V.3
-
4
-
-
0024349674
-
Metaplastic carcinomas of the breast. II. Spindle cell carcinoma
-
DOI 10.1016/0046-8177(89)90065-8
-
Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast. II. Spindle Cell Carcinoma. Human Pathology 1989, 20:732-740. (Pubitemid 19203633)
-
(1989)
Human Pathology
, vol.20
, Issue.8
, pp. 732-740
-
-
Wargotz, E.S.1
Deos, P.H.2
Norris, H.J.3
-
5
-
-
0024417246
-
Metaplastic carcinomas of the breast. III. Carcinosarcoma
-
Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 1989, 67:1490-1499. (Pubitemid 19238967)
-
(1989)
Cancer
, vol.64
, Issue.7
, pp. 1490-1499
-
-
Wargotz, E.S.1
Norris, H.J.2
-
6
-
-
77952879228
-
Carcinoma with metaplasia
-
Philadelphia: Lippincott Williams & Wilkins;
-
Rosen , Peter Paul: Carcinoma with metaplasia. In Rosen's Breast Pathology Third edition. Philadelphia: Lippincott Williams & Wilkins; 2009:470-474.
-
(2009)
Rosen's Breast Pathology Third Edition
, pp. 470-474
-
-
Paul, R.P.1
-
7
-
-
33646080823
-
Metaplastic breast cancer: Clinical significance
-
Beatty JD, Atwood M, Tickman R, Reiner M: Metaplastic breast cancer: clinical significance. The American Journal of Surgery 2006, 191:657-664.
-
(2006)
The American Journal of Surgery
, vol.191
, pp. 657-664
-
-
Beatty, J.D.1
Atwood, M.2
Tickman, R.3
Reiner, M.4
-
8
-
-
33749996039
-
Metaplastic carcinoma of the breast: A clinicopathological review
-
DOI 10.1136/jcp.2005.030536
-
Tse GM, Tan PH, Putti TC, Lui PCW, Chaiwun B, Law BKB: Metaplastic carcinoma of the breast: a clinicopathologic review. J Clin Pathol 2006, 59:1079-1083. (Pubitemid 44570331)
-
(2006)
Journal of Clinical Pathology
, vol.59
, Issue.10
, pp. 1079-1083
-
-
Tse, G.M.1
Tan, P.H.2
Putti, T.C.3
Lui, P.C.W.4
Chaiwun, B.5
Law, B.K.B.6
-
9
-
-
33645289670
-
Biphasic metaplastic sarcomatoid carcinoma of the breast
-
Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz , Babiera G, Hortobagyi GN, Valero V: Biphasic metaplastic sarcomatoid carcinoma of the breast. Annals of Oncology 2006, 17:605-613.
-
(2006)
Annals of Oncology
, vol.17
, pp. 605-613
-
-
Hennessy, B.T.1
Giordano, S.2
Broglio, K.3
Duan, Z.4
Trent, J.5
Buchholz6
Babiera, G.7
Hortobagyi, G.N.8
Valero, V.9
-
10
-
-
24344474204
-
A case of carcinosarcoma of the breast
-
Tokudome N, Sakamoto G, Sakai T, Sarumaru S, Okuyama N, Hori F, Horii R, Akiyama F, Tanabe M, Saito K, Takahashi K, Kasumi F: A case of carcinosarcoma of the breast. Breast Cancer 2005, 12(2):149-153.
-
(2005)
Breast Cancer
, vol.12
, Issue.2
, pp. 149-153
-
-
Tokudome, N.1
Sakamoto, G.2
Sakai, T.3
Sarumaru, S.4
Okuyama, N.5
Hori, F.6
Horii, R.7
Akiyama, F.8
Tanabe, M.9
Saito, K.10
Takahashi, K.11
Kasumi, F.12
-
11
-
-
21844456072
-
Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): Potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?
-
DOI 10.1136/jcp.2004.025163
-
Leibl S, Moinfar F: Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J Clin Pathol 2005, 58:700-704. (Pubitemid 40956822)
-
(2005)
Journal of Clinical Pathology
, vol.58
, Issue.7
, pp. 700-704
-
-
Leibl, S.1
Moinfar, F.2
-
12
-
-
0842286818
-
Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells
-
DOI 10.1038/sj.bjc.6601504
-
Okumo S, Kurebayashi J, Otsuki T, Yamamoto Y, Tanaka K, Sonoo H: Additive antitumor effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells. Br J Cancer 2004, 12;90(1):236-244. (Pubitemid 38174967)
-
(2004)
British Journal of Cancer
, vol.90
, Issue.1
, pp. 236-244
-
-
Okubo, S.1
Kurebayashi, J.2
Otsuki, T.3
Yamamoto, Y.4
Tanaka, K.5
Sonoo, H.6
|